Astrana Health, Inc.
ASTH
$31.40
$0.501.62%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 13.98M | 14.82M | 21.97M | 32.86M | 38.68M |
| Total Other Revenue | 2.02B | 1.71B | 1.57B | 1.42B | 1.35B |
| Total Revenue | 2.03B | 1.72B | 1.59B | 1.45B | 1.39B |
| Cost of Revenue | 1.76B | 1.46B | 1.33B | 1.21B | 1.17B |
| Gross Profit | 271.39M | 259.89M | 259.20M | 241.07M | 214.96M |
| SG&A Expenses | 154.11M | 150.43M | 142.03M | 130.14M | 112.60M |
| Depreciation & Amortization | 27.93M | 24.70M | 21.74M | 18.55M | 17.75M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.95B | 1.64B | 1.50B | 1.36B | 1.30B |
| Operating Income | 89.35M | 84.76M | 95.42M | 92.38M | 84.62M |
| Income Before Tax | 80.82M | 83.64M | 94.84M | 94.43M | 89.84M |
| Income Tax Expenses | 30.89M | 26.02M | 28.23M | 32.21M | 31.99M |
| Earnings from Continuing Operations | 49.93 | 57.62 | 66.61 | 62.22 | 57.85 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -6.78M | 4.84M | 1.81M | 197.00K | 2.87M |
| Net Income | 43.15M | 62.46M | 68.42M | 62.42M | 60.72M |
| EBIT | 89.35M | 84.76M | 95.42M | 92.38M | 84.62M |
| EBITDA | 117.28M | 109.46M | 117.16M | 110.93M | 102.36M |
| EPS Basic | 0.90 | 1.31 | 1.45 | 1.33 | 1.30 |
| Normalized Basic EPS | 0.91 | 1.14 | 1.25 | 1.21 | 1.31 |
| EPS Diluted | 0.89 | 1.30 | 1.44 | 1.32 | 1.29 |
| Normalized Diluted EPS | 0.90 | 1.13 | 1.24 | 1.20 | 1.30 |
| Average Basic Shares Outstanding | 188.90M | 190.09M | 188.95M | 187.81M | 187.11M |
| Average Diluted Shares Outstanding | 190.24M | 191.42M | 190.12M | 188.92M | 188.18M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | 95.76% | 90.72% | 99.45% | 102.24% |